Pneumonia arising from the use of ventilators and feeding tubes in the ICU are disturbingly common and often life threatening. A company based in Israel has developed technology that may help prevent aspiration pneumonia and ventilator associated pneumonia . This article reviews the technology, how it works, and what clinicians should expect from it. The article is an excerpt from the interview of the CEO of the company. Why does this issue arise?
Tube-related reflux and secretion may cause aspiration pneumonia and ventilator associated pneumonia (VAP). Both are dangerous complications for ICU patients, resulting in prolonged length of stay and higher risk of mortality, and both are unrelated to the original reason for hospitalization. Therefore, gastric reflux and saliva must be identified in real-time and treated immediately. In the ICU, nurses and doctors are required to constantly…
